切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2017, Vol. 10 ›› Issue (05) : 612 -616. doi: 10.3877/cma.j.issn.1674-6902.2017.05.031

所属专题: 文献

综述

慢性阻塞性肺疾病急性加重表型的研究进展
翟翠1, 兀小娟1, 宋旸1, 李满祥1,()   
  1. 1. 710061 西安,西安交通大学第一附属医院呼吸与危重症学科
  • 收稿日期:2016-08-19 出版日期:2017-10-20
  • 通信作者: 李满祥

Progress of the phenotype in acute exacerbation of chronic obstructive pulmonary disease

Cui Zhai1, Xiaojuan Wu1, Yang Song1   

  • Received:2016-08-19 Published:2017-10-20
引用本文:

翟翠, 兀小娟, 宋旸, 李满祥. 慢性阻塞性肺疾病急性加重表型的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2017, 10(05): 612-616.

Cui Zhai, Xiaojuan Wu, Yang Song. Progress of the phenotype in acute exacerbation of chronic obstructive pulmonary disease[J/OL]. Chinese Journal of Lung Diseases(Electronic Edition), 2017, 10(05): 612-616.

1
任成山,钱桂生. 慢性阻塞性肺疾病发病机制研究现状与展望[J/CD]. 中华肺部疾病杂志(电子版), 2009, 2(2): 104-115.
2
Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD[J]. Chest, 2000, 117(2 Suppl): 5S-9S.
3
MacDonald M, Korman T, King P, et al. Exacerbation phenotyping in chronic obstructive pulmonary disease[J]. Respirology, 2013, 18(8): 1280-1281.
4
李慧平,张睢扬,王英,等. 慢性阻塞性肺疾病急性加重机械通气治疗后酸碱平衡状态及电解质的变化[J/CD]. 中华肺部疾病杂志(电子版), 2013, 6(3): 216-221.
5
Carolan BJ, Sutherland ER. Clinical phenotypes of chronic obstructive pulmonary disease and asthma: recent advances[J]. J Allergy Clin Immunol, 2013, 131(3): 627-634.
6
Albertson TE, Louie S, Chan AL. The diagnosis and treatment of elderly patients with acute exacerbation of chronic obstructive pulmonary disease and chronic bronchitis[J]. J Am Geriatr Soc, 2010, 58(3): 570-579.
7
Chhabra SK, Dash DJ. Acute exacerbations of chronic obstructive pulmonary disease: causes and impacts[J]. Indian J Chest Dis Allied Sci, 2014, 56(2): 93-104.
8
Fagon JY, Chastre J, Trouillet JL, et al. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients[J]. Am Rev Respir Dis, 1990, 142(5): 1004-1008.
9
Beckham JD, Cadena A, Lin J, et al. Respiratory viral infections in patients with chronic, obstructive pulmonary disease[J]. J Infect, 2005, 50(4): 322-330.
10
Kherad O, Bridevaux PO, Kaiser L, et al. Is Acute Exacerbation of COPD (AECOPD) Related to Viral Infection Associated with Subsequent Mortality or Exacerbation Rate?[J]. Open Respir Med J, 2014, 8: 18-21.
11
Papaetis GS, Anastasakou E, Orphanidou D. Chlamydophila pneumoniae infection and COPD: more evidence for lack of evidence?[J]. Eur J Intern Med, 2009, 20(6): 579-585.
12
Blasi F, Damato S, Cosentini R, et al. Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment[J]. Thorax, 2002, 57(8): 672-676.
13
Dimopoulos G, Lerikou M, Tsiodras S, et al. Viral epidemiology of acute exacerbations of chronic obstructive pulmonary disease[J]. Pulm Pharmacol Ther, 2012, 25(1): 12-18.
14
Mallia P, Footitt J, Sotero R, et al. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2012, 186(11): 1117-1124.
15
Lee YM. Chronic obstructive pulmonary disease: respiratory review of 2014[J]. Tuberc Respir Dis (Seoul), 2014, 77(4): 155-160.
16
Huerta A, Soler N, Esperatti M, et al. Importance of Aspergillus spp. isolation in Acute exacerbations of severe COPD: prevalence, factors and follow-up: the FUNGI-COPD study[J]. Respir Res, 2014, 15: 17.
17
Gao P, Zhang J, He X, et al. Gibson. Sputum Inflammatory Cell-Based Classification of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J]. PLoS One, 2013, 8(5): e57678.
18
White AJ, Gompertz S, Stockley RA. Chronic obstructive pulmonary disease .6: The aetiology of exacerbations of chronic obstructive pulmonary disease[J]. Thorax, 2003, 58(1): 73-80.
19
Stockley RA, Bayley D, Hill SL, et al. Assessment of airway neutrophils by sputum colour: correlation with airways inflammatio[J]. Thorax, 2001, 56(5): 366-372.
20
Bafadhel M, McKenna S, Terry S, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers[J]. Am J Respir Crit Care Med, 2011, 184(6): 662-671.
21
Papi A, Bellettato CM, Braccioni F, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations[J]. Am J Respir Crit Care Med, 2006, 173(10): 1114-1121.
22
Peces-Barba G, Barberà JA, Agustí A, et al. Diagnosis and management of chronic obstructive pulmonary disease: joint guidelines of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Latin American Thoracic Society (ALAT)[J]. Arch Bronconeumo, 2008, 44(5): 271-281.
23
Wedzicha JA, Donaldson GC. Exacerbations of Chronic Obstructive Pulmonary Disease[J]. Respir Care, 2003, 48(12): 1204-1213.
24
Rizkallah J, Man SF, Sin DD. Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis[J]. Chest, 2009, 135(3): 786-793.
25
Kitaguchi Y, Komatsu Y, Fujimoto K, et al. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma[J]. Int J Chron Obstruct Pulmon Dis, 2012, 7: 283-289.
26
Hardin M, Silverman EK, Barr RG, et al. The clinical features of the overlap between COPD and asthma[J]. Respir Res, 2011, 12: 127.
27
Martinez FJ, Standiford C, Gay SE. Is it asthma or COPD? The answer determines proper therapy for chronic airflow obstruction[J]. Postgrad Med, 2005, 117(3): 19-26.
28
Huerta A, Crisafulli E, Menendez R, et al. Pneumonic and nonpneumonic exacerbations of COPD: inflammatory response and clinical characteristics[J]. Chest, 2013, 144(4): 1134-1142.
29
Dodd JW, Charlton RA, van den Broek MD, et al. Cognitive dysfunction in patients hospitalized with acute exacerbation of COPD[J]. Chest, 2013, 144(1): 119-127.
30
Brekke PH, Omland T, Smith P, et al. Underdiagnosis of myocardial infarction in COPD-Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbation[J]. Respir Med, 2008, 102(9): 1243-1247.
31
Patel AR, Kowlessar BS, Donaldson GC, et al. Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2013, 188(9): 1091-1099.
32
Quint JK, Baghai-Ravary R, Donaldson GC, et al. Relationship between depression and exacerbations in COPD[J]. Eur Respir J, 2008, 32(1): 53-60.
33
López Torres I, Torres-Sánchez I, Martín Salvador A, et al. Cognitive impairment, nutritional status and clinical profile in chronic obstructive pulmonary disease[J]. Nutr Hosp, 2014, 30(5): 1152-1159.
34
Thomas M, Radwan A, Stonham C, et al. COPD exacerbation frequency,pharmacotherapy and resource use: an observational study in UK primary care[J]. COPD, 2014, 11(3): 300-309.
35
McGarvey L, Lee AJ, Roberts J, et al. Characterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care population[J]. Respir Med, 2015, 109(2): 228-237.
36
Perera WR, Hurst JR, Wilkinson TM, et al. Inflammatory changes, recovery and recurrence at COPD exacerbation[J]. Eur Respir J, 2007, 29(3): 527-534.
37
Burgel PR. Chronic cough and sputum production: a clinical COPD phenotype?[J]. Eur Respir J, 2012, 40(1): 4-6.
38
Dalal AA, Shah M, Lunacsek O, et al. Clinical and economic burden of patients diagnosed with COPD with comorbid cardiovascular disease[J]. Respir Med, 2011, 105(10): 1516-1522.
[1] 张刚, 秦勇, 黄超, 薛震, 吕松岑. 基于骨关节炎软骨细胞表型转化的新兴治疗靶点[J/OL]. 中华关节外科杂志(电子版), 2024, 18(03): 352-362.
[2] 刘洋, 盛赵莹, 孙琳琳. 白细胞介素6启动子通过调控人端粒酶逆转录酶减轻细胞炎症和DNA损伤[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(02): 104-110.
[3] 张雪灵, 陈玮彬, 魏雯硕, 陈明, 诸宏伟. 努南综合征的临床特点与治疗效果分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(02): 192-199.
[4] 胡思平, 熊性宇, 徐航, 杨璐. 衰老相关分泌表型因子在前列腺癌发生发展中的作用机制[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 425-434.
[5] 沈琪乐, 赵勤华, 宫素岗, 刘锦铭, 王岚, 邱宏玲. COPD 稳定期患者血清CC16 蛋白表达与肺功能、肺气肿表型的关系分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 690-695.
[6] 方晓玉, 王婷, 赵珊, 陈锋. HALP指数对AECOPD并发呼吸衰竭患者ICU结局的预测意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 639-641.
[7] 杨万荣, 任治坤, 时新颍. 沙丁胺醇雾化吸入脾多肽治疗AECOPD的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 609-612.
[8] 程炜炜, 张青, 张诚实, 冯契靓, 陈荣荣, 赵云峰. 全身免疫炎症指数与慢性阻塞性肺疾病急性加重期病情严重程度相关性分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 580-584.
[9] 陈杨, 李茜, 杨中华. 慢性阻塞性肺疾病急性加重期合并VTE抗凝治疗的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(02): 316-319.
[10] 周文欢, 杨黎. AECOPD低钠血症发生风险及预测因素分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(02): 313-315.
[11] 陈婷婷, 李春娟. 经鼻高流量湿化氧疗治疗AECOPD伴Ⅱ型呼吸衰竭的临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(02): 276-279.
[12] 赵雅, 张丽, 季学丽, 黄夕华, 李晨, 金伦. 急诊早期气道规范化管理对AECOPD并发呼吸衰竭预后的影响[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(01): 134-136.
[13] 张智, 董志伟, 徐祖鑫, 姜莉鑫, 张玉辉, 顾国利. Peutz-Jeghers综合征基因型研究及临床诊治进展[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(01): 6-13.
[14] 卢斌, 张天琪, 徐烨, 刘方奇. 中国人群经典型家族性腺瘤性息肉病的临床、病理和分子特征[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(01): 38-44.
[15] 胡杰, 蔡国龙. 脓毒症合并低心功能指数患者PiCCO参数的聚类分析[J/OL]. 中华重症医学电子杂志, 2024, 10(01): 25-30.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?